Prevention of meningococcal disease during the Hajj and Umrah mass gatherings: Past and current measures and future prospects

International Journal of Infectious Diseases

Volumn 47, Issue , 2016, Pages 71-78

  Yezli, Saber ^a   Bin Saeed, Abdulaziz A ^a,b   Assiri, Abdullah M ^a   Alhakeem, Rafat F ^a   Yunus, Muslim A ^a   Turkistani, Abdulhafiz M ^a   Booy, Robert ^c   Alotaibi, Badriah M ^a  

^a MINISTRY OF HEALTH   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Hajj; Mass gathering; Meningitis; Meningococcal disease; Prevention; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; VACCINE;

ARTICLE; CHEMOPROPHYLAXIS; DISEASE SURVEILLANCE; EPIDEMIC; HAJJ PILGRIMS; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; MASS IMMUNIZATION; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PATIENT COMPLIANCE; RISK FACTOR; SAUDI ARABIA; SOCIETY; UMRAH MASS GATHERINGS; WORLD HEALTH ORGANIZATION; CROWDING (AREA); DEMOGRAPHY; DISEASE OUTBREAKS; EPIDEMIOLOGY; FEMALE; IMMUNOLOGY; ISLAM; LEISURE; MALE; MENINGOCOCCAL INFECTIONS; TRANSMISSION; TRAVEL; VACCINATION;

CROWDING; DEMOGRAPHY; DISEASE OUTBREAKS; FEMALE; HOLIDAYS; HUMANS; ISLAM; MALE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; SAUDI ARABIA; TRAVEL; VACCINATION; VACCINES, CONJUGATE;

EID: 84979713567     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.12.010     Document Type: Article

References (67)

1. Rosenstein, N.E., Perkins, B.A., Stephens, D.S., Popovic, T., Hughes, J.M., Meningococcal disease. N Engl J Med 344 (2001), 1378–1388.
2. Chang, Q., Tzeng, Y.L., Stephens, D.S., Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol 4 (2012), 237–245.
3. Yezli, S., Wilder-Smith, A., Bin Saeed, A., Carriage of Neisseria meningitidis in the Hajj and Umrah mass gatherings. Int J Infect Dis, 2015 Nov 20 [Epub ahead of print].
4. Yezli, S., Assiri, A.M., Alhakeem, R.F., Turkistani, A.M., Alotaibi, B., Meningococcal disease during the Hajj and Umrah mass gatherings. Int J Infect Dis, 2016.
5. World Health Organization. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec 86 (2011), 521–539.
6. Memish, Z.A., Shibl, A.M., Consensus building and recommendations based on the available epidemiology of meningococcal disease in Gulf Cooperation Council States. Travel Med Infect Dis 9 (2011), 60–66.
7. Vipond, C., Care, R., Feavers, I.M., History of meningococcal vaccines and their serological correlates of protection. Vaccine 30:Suppl 2 (2012), B10–B17.
8. Cohn, A.C., MacNeil, J.R., Clark, T.A., Ortega-Sanchez, I.R., Briere, E.Z., Meissner, H.C., et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62 (2013), 1–28.
9. Borrow, R., Meningococcal disease and prevention at the Hajj. Travel Med Infect Dis 7 (2009), 219–225.
10. Zlotnick, G.W., Jones, T.R., Liberator, P., Hao, L., Harris, S., McNeil, L.K., et al. The discovery and development of a novel vaccine to protect against Neisseria meningitidis serogroup B disease. Hum Vaccin Immunother 11 (2015), 5–13.
11. Folaranmi, T., Rubin, L., Martin, S.W., Patel, M., MacNeil, J.R., Use of serogroup B meningococcal vaccines in persons aged >/=10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep 64 (2015), 608–612.
12. Harrison, L.H., Vaccines for prevention of group B meningococcal disease: not your father's vaccines. Vaccine 33 (2015), D32–D38.
13. Shibl, A., Tufenkeji, H., Khalil, M., Memish, Z., Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine. East Mediterr Health J 19 (2013), 389–392.
14. Alqarni, H., Memish, Z.A., Assiri, A.M., Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj)—2015. J Epidemiol Glob Health, 2015, 10.1016/j.jegh.2015.07.001 pii: S2210-6006(15)00067-2, [Epub ahead of print].
15. Harcourt, B.H., Anderson, R.D., Wu, H.M., Cohn, A.C., MacNeil, J.R., Taylor, T.H., et al. Population-based surveillance of Neisseria meningitidis antimicrobial resistance in the United States. Open Forum Infect Dis, 2, 2015, ofv117.
16. Alborzi, A., Oskoee, S., Pourabbas, B., Alborzi, S., Astaneh, B., Gooya, M.M., et al. Meningococcal carrier rate before and after Hajj pilgrimage: effect of single dose ciprofloxacin on carriage. East Mediterr Health J 14 (2008), 277–282.
17. Singhal, S., Purnapatre, K.P., Kalia, V., Dube, S., Nair, D., Deb, M., et al. Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India. Emerg Infect Dis 13 (2007), 1614–1616.
18. al-Gahtani, Y.M., el Bushra, H.E., al-Qarawi, S.M., al-Zubaidi, A.A., Fontaine, R.E., Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah (Mecca), Saudi Arabia, 1992. Epidemiol Infect 115 (1995), 399–409.
19. Moore, P.S., Reeves, M.W., Schwartz, B., Gellin, B.G., Broome, C.V., Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet 2 (1989), 260–263.
20. Novelli, V.M., Lewis, R.G., Dawood, S.T., Epidemic group A meningococcal disease in Haj pilgrims. Lancet, 2, 1987, 863.
21. Moore, P.S., Harrison, L.H., Telzak, E.E., Ajello, G.W., Broome, C.V., Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA 260 (1988), 2686–2689.
22. Centers for Disease Control and Prevention (CDC). Meningococcal disease among travelers returning from Saudi Arabia. MMWR Morb Mortal Wkly Rep, 36, 1987, 559.
23. Centers for Disease Control and Prevention (CDC). Recommendation of the Immunization Practices Advisory Committee: meningococcal vaccines. MMWR Morb Mortal Wkly Rep 34 (1985), 255–259.
24. Memish, Z.A., Meningococcal disease and travel. Clin Infect Dis 34 (2002), 84–90.
25. Bushra, H.E., Mawlawi, M.Y., Fontaine, R.E., Afif, H., Meningococcal meningitis group A: a successful control of an outbreak by mass vaccination. East Afr Med J 72 (1995), 715–718.
26. World Health Organization. Health conditions for travellers to Saudi Arabia— Pilgrimage to Mecca (Hajj). Wkly Epidemiol Rec 50 (1996), 380–381.
27. Lingappa, J.R., Al-Rabeah, A.M., Hajjeh, R., Mustafa, T., Fatani, A., Al-Bassam, T., et al. Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis 9 (2003), 665–671.
28. el Bushra, H.E., Hassan, N.M., Al-Hamdan, N.A., Al-Jeffri, M.H., Turkistani, A.M., Al-Jumaily, A., et al. Determinants of case fatality rates of meningococcal disease during outbreaks in Makkah, Saudi Arabia, 1987–97. Epidemiol Infect 125 (2000), 555–560.
29. Centers for Disease Control and Prevention (CDC). Change in recommendation for meningococcal vaccine for travelers. MMWR Morb Mortal Wkly Rep, 48, 1999, 104.
30. World Health Organization. Health conditions for travellers to Saudi Arabia—pilgrimage to Mecca (Hajj). Wkly Epidemiol Rec 75 (2000), 7–8.
31. Mayer, L.W., Reeves, M.W., Al-Hamdan, N., Sacchi, C.T., Taha, M.K., Ajello, G.W., et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J Infect Dis 185 (2002), 1596–1605.
32. World Health Organization. Meningococcal disease, serogroup W135 (Update). Wkly Epidemiol Rec 76 (2001), 213–216.
33. Centers for Disease Control and Prevention (CDC). Update: Assessment of risk for meningococcal disease associated with the Hajj 2001. MMWR Morb Mortal Wkly Rep 50 (2001), 221–222.
34. Memish, Z.A., Alrajhi, A.A., Meningococcal disease. Saudi Med J 23 (2002), 259–264.
35. Balkhy, H.H., Memish, Z.A., Almuneef, M.A., Osoba, A.O., Neisseria meningitidis W-135 carriage during the Hajj season 2003. Scand J Infect Dis 36 (2004), 264–268.
36. Khan, M.A., Outbreaks of meningococcal meningitis during Hajj: changing face of an old enemy. J Pak Med Assoc 53 (2003), 1–3.
37. Hahne, S.J., Gray, S.J., Jean, F., Aguilera, Crowcroft, N.S., Nichols, T., et al. W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001. Lancet 359 (2002), 582–583.
38. World Health Organization. Meningococcal disease, serogroup W135. Wkly Epidemiol Rec, 76, 2001, 142.
39. Memish, Z., Al Hakeem, R., Al Neel, O., Danis, K., Jasir, A., Eibach, D., Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011. Euro Surveill, 18, 2013 pii: 20581.
40. Khalil, M., Al-Mazrou, Y., Balmer, P., Bramwell, J., Andrews, N., Borrow, R., Immunogenicity of meningococcal ACYW135 polysaccharide vaccine in Saudi children 5 to 9 years of age. Clin Diagn Lab Immunol 12 (2005), 1251–1253.
41. World Health Organization. Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj). Wkly Epidemiol Rec 82 (2007), 385–388.
42. World Health Organization. Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj), 2015. Wkly Epidemiol Rec 90 (2015), 381–384.
43. Al-Ghamdi, A.S., Kabbash, I.A., Awareness of healthcare workers regarding preventive measures of communicable diseases among Hajj pilgrims at the entry point in Western Saudi Arabia. Saudi Med J 32 (2011), 1161–1167.
44. Al-Azeri, A., Ashoor, B., Altuhami, H., Al-Rabeah, A., Alhamdan, N., Aljefri, M., et al. Meningococcal carriage among Hajjis in Makkah, 1421 H. Saudi Epidemiology Bulletin 9 (2002), 3–4.
45. Memish, Z.A., Assiri, A., Almasri, M., Alhakeem, R.F., Turkestani, A., Al Rabeeah, A.A., et al. Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J Infect Dis 210 (2014), 1067–1072.
46. Memish, Z.A., Yezli, S., Almasri, M., Assiri, A., Turkestani, A., Findlow, H., et al. Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims. Int J Infect Dis 28 (2014), 171–175.
47. Ceyhan, M., Anis, S., Htun-Myint, L., Pawinski, R., Soriano-Gabarro, M., Vyse, A., Meningococcal disease in the Middle East and North Africa: an important public health consideration that requires further attention. Int J Infect Dis 16 (2012), e574–e582.
48. El Bashir, H., Rashid, H., Memish, Z.A., Shafi, S., Meningococcal vaccine coverage in Hajj pilgrims. Lancet, 369, 2007, 1343.
49. Madani, T.A., Ghabrah, T.M., Meningococcal, influenza virus, and hepatitis B virus vaccination coverage level among health care workers in Hajj. BMC Infect Dis, 7, 2007, 80.
50. Balkhy, H.H., Memish, Z.A., Osoba, A.O., Meningococcal carriage among local inhabitants during the pilgrimage 2000–2001. Int J Antimicrob Agents 21 (2003), 107–111.
51. Ceyhan, M., Celik, M., Demir, E.T., Gurbuz, V., Aycan, A.E., Unal, S., Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj pilgrims who had received the quadrivalent meningococcal polysaccharide vaccine. Clin Vaccine Immunol 20 (2013), 66–68.
52. El Bashir, H., Coen, P.G., Haworth, E., Taylor, S., Mifsud, A., El, B.A., et al. Meningococcal W135 carriage; enhanced surveillance amongst east London Muslim pilgrims and their household contacts before and after attending the 2002 Hajj. Travel Med Infect Dis 2 (2004), 13–15.
53. Khalil, M.K., Borrow, R., Serogroup B meningococcal disease during Hajj: preparing for the worst scenario. Travel Med Infect Dis 7 (2009), 231–234.
54. Wilder-Smith, A., Barkham, T.M., Ravindran, S., Earnest, A., Paton, N.I., Persistence of W135 Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts. Emerg Infect Dis 9 (2003), 123–126.
55. Hahne, S., Handford, S., Ramsay, M., W135 meningococcal carriage in Hajj pilgrims. Lancet 360 (2002), 2089–2090.
56. Husain, E.H., Dashti, A.A., Electricwala, Q.Y., Abdulsamad, A.M., Al-Sayegh, S., Absence of Neisseria meningitidis from throat swabs of Kuwaiti pilgrims after returning from the Hajj. Med Princ Pract 19 (2010), 321–323.
57. Nicolas, P., Ait, M.N., Al-Awaidy, S., Al Busaidy, S., Sulaiman, N., Issa, M., et al. Pharyngeal carriage of serogroup W135 Neisseria meningitidis in Hajjees and their family contacts in Morocco, Oman and Sudan. APMIS 113 (2005), 182–186.
58. Lapadula, G., Vigano, F., Fortuna, P., Dolara, A., Bramati, S., Soria, A., et al. Imported ciprofloxacin-resistant Neisseria meningitidis. Emerg Infect Dis 15 (2009), 1852–1854.
59. Ashgar, S., El-Said, H., Johargy, A., Momenah, A., Asghar, A., Sorour, A., et al. Prevalence of nasal carriage of Neisseria meningitidis among Umrah visitors and pilgrims during Umrah and Hajj season. Global Advanced Research Journal of Microbiology 2 (2013), 141–149.
60. Goodman, A.L., Masuet-Aumatell, C., Halbert, J., Zuckerman, J.N., Awareness of meningococcal disease among travelers from the United Kingdom to the meningitis belt in Africa. Am J Trop Med Hyg 91 (2014), 281–286.
61. Ninis, N., Phillips, C., Bailey, L., Pollock, J.I., Nadel, S., Britto, J., et al. The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. BMJ, 330, 2005, 1475.
62. Dowson, A., Russ, S., Sevdalis, N., Cooper, M., De Munter, C., How in situ simulation affects paediatric nurses’ clinical confidence. Br J Nurs, 22, 2013, 610 612–17.
63. Nadel, S., Kroll, J.S., Diagnosis and management of meningococcal disease: the need for centralized care. FEMS Microbiol Rev 31 (2007), 71–83.
64. Dull, P.M., Abdelwahab, J., Sacchi, C.T., Becker, M., Noble, C.A., Barnett, G.A., et al. Neisseria meningitidis serogroup W-135 carriage among US travelers to the 2001 Hajj. J Infect Dis 191 (2005), 33–39.
65. Phrom-in, S., Surveillance for meningococcal carriage by Muslims returning from the Hajj to Hat Yai Airport, Thailand. Southeast Asian J Trop Med Public Health 33:Suppl 3 (2002), 127–130.
66. Wilder-Smith, A., Barkham, T.M., Chew, S.K., Paton, N.I., Absence of Neisseria meningitidis W-135 electrophoretic type 37 during the Hajj, 2002. Emerg Infect Dis 9 (2003), 734–737.
67. Metanat, M., Sharifi-Mood, B., Sanei-Moghaddam, S., Sepehri-Rad, N., Pharyngeal carriage rate of Neisseria meningitidis before and after the Hajj pilgrimage, in Zahedan (southeastern Iran), 2012. Turkish Journal of Medical Sciences 45 (2015), 1405–1407.